Lee et al reviewed deprescribing for patients with rheumatic musculoskeletal disorders. A simple algorithm for deprescribing for a patient with rheumatoid arthritis is presented. The authors are from the University of Michigan, University of Washington Seattle, and Texas Southwestern Medical Center Dallas.
Patient selection: rheumatoid arthritis
Evaluation: all medications and their indications
Drug
Consider Deprescribing
Glucocorticoid
not lowest possible dose OR not shortest duration possible
DMARD
RA in remission for >= 6 months
for comorbidity or symptoms
potentially inappropriate or unnecessary
Considerations when deprescribing or tapering:
(1) likelihood of relapse or worsening of condition after discontinuation
(2) withdrawal reaction
(3) impact on patient goals and preferences
To read more or access our algorithms and calculators, please log in or register.
